Original Research

Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections

Mucke J, Brinks R, Fischer-Betz R, Richter JG, Sander O, Schneider M, Chehab G

Patient Preference and Adherence 2019, 13:1889-1894

Published Date: 4 November 2019